Receptor agonists

Details Receptor agonists Receptor agonists

2004-01-27

2009-12-01

Kifle, Bruck (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C540S469000, C540S552000, C514S302000

Reexamination Certificate

active

07625887

ABSTRACT:
It is intended to provide a TGR5 receptor agonist containing a fused ring compound represented by the following general formula, its salt or a prodrug thereof: (1) wherein ring A represents an optionally substituted aromatic ring; and the ring B′ represents a 5- to 8-membered ring having one or more substituents; which is useful in treating various diseases.

REFERENCES:
patent: 3555034 (1971-01-01), Diebold et al.
patent: 3987047 (1976-10-01), Griss et al.
patent: 4220778 (1980-09-01), Ellefson et al.
patent: 4329341 (1982-05-01), Rochricht et al.
patent: 4647560 (1987-03-01), Boltze et al.
patent: 4820834 (1989-04-01), Evans et al.
patent: 5137890 (1992-08-01), Sanfilippo et al.
patent: 5324726 (1994-06-01), Bock et al.
patent: 6150357 (2000-11-01), Salata et al.
patent: 0167919 (1986-01-01), None
patent: 0 284 256 (1988-09-01), None
patent: 0 567 026 (1993-10-01), None
patent: 0 705 607 (1996-04-01), None
patent: 0733632 (1996-09-01), None
patent: 1 273 659 (2003-01-01), None
patent: 1 347 052 (2003-09-01), None
patent: 1 378 749 (2004-01-01), None
patent: 1 407 782 (2004-04-01), None
patent: 09-291034 (1997-11-01), None
patent: WO 94/22825 (1994-10-01), None
patent: WO 95/28399 (1995-10-01), None
patent: WO 97/10224 (1997-03-01), None
patent: WO 97/30992 (1997-08-01), None
patent: WO 98/47882 (1998-10-01), None
patent: WO 99/38844 (1999-08-01), None
patent: WO 99/47132 (1999-09-01), None
patent: WO 01/55121 (2001-08-01), None
patent: WO 01/77325 (2001-10-01), None
patent: WO 02/40669 (2002-05-01), None
patent: WO 02/084286 (2002-10-01), None
patent: WO 02/099388 (2002-12-01), None
patent: WO 03/002147 (2003-01-01), None
patent: WO 04/033436 (2004-04-01), None
patent: WO 2004/043468 (2004-05-01), None
C. Papageorgiou, et al., “A Non-Peptide Ligand for the Somatostatin Receptor Having a Benzodiazepinone Structure”, Biorganic & Medical Chemistry Letters, (1996), pp. 2670272, vol. 6, No. 3.
A. Terada, et al., “Studies on Benzodizepinooxazoles. III. Reactions and Rearrangements ofBenzo[6,7]-1,4-diazepino-[5,4-b]oxazole Derivatives”, Chem. Pharm. Bull., (1973), pp. 742-751, vol. 21, No. 4.
H. Breslin, et al., “Synthesis and Anti-HIV Activity of 1,3,4,5-Tetrahydro-2H-1,4-benzodiazepin-2-one J(TBO) Derivatives. Truncated 4,5,6,7-Tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-ones J(TIBO) Analogues”, Bioorganic & Medicinal Chemistry, (1999), pp. 2427-2436, vol. 7.
M. Kajtar, et al., “Chrioptical Properties and Conformation of 4,5-Saturated Derivatives of 5-Aryl-1,4-benzodiazepin-2-ones”, Croatica Chemica Acta, J(1989), pp. 245-265, 62 (2A).
Maruyama, Takaharu et al., “Identification of Membrane-Type Receptor For Bile Acids (M-BAR),” Biochemical and Biophysical Research Communications, vol. 298, No. 5, Nov. 15, 2002, pp. 714-719.
Zhang, Zinfang et al., “Solid-Phase Synthesis of Tetrahydro-1,4-Benzodiazepin-2-one derivatives,” Molecular Diversity, vol. 5, No. 3, 2000, pp. 127-130.
Supplementary European Search Report for EP 04705536.3 dated May 13, 2009.

Affiliated with

Also associated with

Rating

Receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Receptor agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4149579